Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.39 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.39 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | CES1 | P23141 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | MYC | P01106 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | GSTP1 | P09211 | 2/20 | 0.34 |
| ▸ | GSTM2 | P28161 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAX | P61244 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6496478 | 0.98 | TXNRD1 (0.39) | TXNRD1TXNRD3TXNRD2CES2CES1 | |
| SCHEMBL5713914 | 0.87 | TXNRD1 (0.40) | TXNRD1TXNRD3TXNRD2GSTP1GSTM2 | |
| SCHEMBL5713669 | 0.86 | TXNRD1 (0.41) | TXNRD1TXNRD3TXNRD2MYCMEN1 | |
| SCHEMBL5713920 | 0.84 | TXNRD1 (0.40) | TXNRD1TXNRD3TXNRD2MEN1KMT2A | |
| SCHEMBL5713646 | 0.83 | TXNRD1 (0.40) | TXNRD1TXNRD3TXNRD2GSTP1GSTM2 | |
| SCHEMBL5713917 | 0.82 | TXNRD1 (0.40) | TXNRD1TXNRD3TXNRD2MEN1KMT2A | |
| SCHEMBL5714048 | 0.82 | TXNRD1 (0.40) | TXNRD1TXNRD3TXNRD2MEN1KMT2A | |
| SCHEMBL5713657 | 0.81 | TXNRD1 (0.40) | TXNRD1TXNRD3TXNRD2GSTP1GSTM2 | |
| SCHEMBL5713695 | 0.81 | TXNRD1 (0.37) | TXNRD1TXNRD3TXNRD2GSTP1GSTM2 | |
| SCHEMBL5713677 | 0.79 | TXNRD1 (0.38) | TXNRD1TXNRD3TXNRD2GSTP1GSTM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6869454-B2 | 7-Nitro-2,1,3-benzoxadiazole and 7-nitro-2,1,3-benzthiadiazole derivatives, as well dyeing agents for keratin fibers containing these compounds | WELLA AKTIENGESELLSCHAFT (DE) | 2005-03-22 | — | — | US | claimed |
| US-20040226108-A1 | 7-Nitro-2,1,3-benzoxadiazole and 7-nitro-2,1,3-benzthiadiazole derivatives, as well dyeing agents for keratin fibers containing these compounds | Wella GmbH (DE) | 2004-11-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040226108-A1 | 7-Nitro-2,1,3-benzoxadiazole and 7-nitro-2,1,3-benzthiadiazole derivatives, as well dyeing agents for keratin fibers containing these compounds | KRT18, NUCB2, NDUFA3 | TXNRD1 704/4885TXNRD3 789/4885TXNRD2 277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.